Pluri Inc. is a biotechnology company leveraging its proprietary 3D cell expansion platform to develop innovative products across regenerative medicine, food tech, and agri-tech. By cultivating human, animal, and plant cells, Pluri delivers cutting-edge solutions to address global challenges in health and sustainability. The company’s technology is being utilized in clinical trials for conditions like critical limb ischemia and acute radiation syndrome, as well as in creating sustainable food and agricultural products. With a mission to promote global well-being, Pluri Inc. is redefining the potential of cell-based technologies across diverse industries.